These plant compounds come from grape seeds and pine bark. Human evidence shows modest support for vein comfort and for some blood-pressure and blood marks of oxidized fat, not a shown extension of life. Effects mainly show up with higher starting blood pressure or vein symptoms. Stomach upset is the usual complaint. Several commercial grape-seed bottles have contained peanut-skin extract. (Full Review)

Protocol

Grape-seed vascular band

150–300 mg/day

Extract standardized to about 90–95% proanthocyanidins; often 150 mg twice daily. Low-normal pressure is a reason to use the bottom of the dose band

Time of day and split doses

Morning and midday with food

Monomer half-life about 2–4 hours; twice-daily dosing

Pycnogenol pattern (Horphag)

100–200 mg/day, often split

65–75% procyanidin pine-bark extract; venous and osteoarthritis trials dominate

Time to effect

Blood pressure

4–6 weeks

Recedes over 4 weeks after stopping

Sitting edema

4–6 weeks

Less leg-volume expansion during six-hour sits

Venous reflux

12 weeks

Reflux-time and symptom-score protocol length

Benefits

Medium: Blood pressure reduction; chronic venous symptoms, reflux, and sitting edema; lower oxidative lipid marks

Low: Small shifts in blood fats; fasting glucose, not glycated hemoglobin; liver fat build-up in non-alcoholic fatty liver disease; retinal hard exudates in non-proliferative diabetic retinopathy; osteoarthritis symptom relief; skin hydration and elasticity; erectile function with arginine combinations

Speculative: Senolytic lifespan extension via procyanidin C1

Contraindications

Pregnancy and lactation (human safety not established)

Known peanut allergy unless the product is peanut-skin–negative by a specific assay

Documented grape or pine-bark allergy

Active pathological bleeding or surgery in the coming 1–2 weeks

Uncontrolled hypotension or syncope (fainting) on current vasodilators

Key Interactions

Antihypertensives (amlodipine, lisinopril, losartan)

Nitrates and nitric-oxide donors (nitroglycerin, isosorbide, beetroot, L-arginine, L-citrulline)

Antiplatelet and anticoagulant drugs (aspirin, clopidogrel, warfarin, apixaban, heparin)

Other blood-thinning supplements (high-dose fish oil, ginkgo, high-dose vitamin E, nattokinase)

Iron supplements and iron-rich meals (2–4 hour separation)

CYP1A2 substrates (clozapine, tizanidine, some caffeine-heavy regimens)

Glucose-lowering drugs (metformin, insulin, empagliflozin)

Risk & Side Effects

Medium: Gastrointestinal upset

Low: Headache and dizziness; lower serum iron at very high doses; additive blood-pressure lowering; product substitution and allergy risk

Speculative: Bleeding from antiplatelet or anticoagulant activity

Monitoring

Marker	Target	Why
Home systolic/diastolic BP	110–120 / 70–80 mmHg	Main vascular endpoint in grape-seed trials
hs-CRP	<0.7 mg/L (functional often <1.0)	Low-grade inflammation / oxidative-stress companion
Fasting LDL cholesterol	Track change from own baseline (functional often <80–100 mg/dL)	Small LDL/triglyceride shifts in some pools
Fasting triglycerides	<100 mg/dL	Proanthocyanidin lipid pools emphasize triglycerides
Fasting glucose	75–90 mg/dL	Small fasting-plasma-glucose signal; glycated hemoglobin often unchanged
Serum ferritin (and iron if ferritin low)	Ferritin roughly 50–150 ng/mL	High-dose OPC iron lowering

Cadence: 4-week, 12-week, then every 6–12 months; home blood pressure several mornings per week for the first month; fasting lipids, glucose, and hs-CRP at 12 weeks if those were part of the rationale; ferritin if high-dose or iron is low

Qualitative Assessment

Leg heaviness, sock marks, and evening swelling
Standing dizziness or unusually low home blood-pressure readings
Gut comfort (nausea, loose stool)
Perceived stress and daytime energy, without treating those as longevity proofs
Skin ease or flushing only if that was a stated reason for use

OPCs for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment